Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, today announced an additional $6M in Series B funding, bringing its total Series B raise to $32M. The follow-on round includes new backing from a San Francisco-based investor and marquee angel investors, along with continued support from Alumni Ventures and Joyance Partners..

Epicore Biosystems（Epicore），一家开发先进汗液感应可穿戴设备的数字健康解决方案领导者，今天宣布在B轮融资中额外获得600万美元，使其B轮融资总额达到3200万美元。此后续轮融资包括来自旧金山投资者和知名天使投资者的新支持，以及Alumni Ventures和Joyance Partners的持续支持。

This latest investment follows Epicore's initial $26M Series B raise led by the Steele Foundation for Hope, and positions the company to accelerate its global expansion and scale next-generation sweat-sensing technologies.

Epicore 最新一轮融资是在由 Steele 希望基金会领投的 2600 万美元 B 轮融资之后，这一定位将推动公司加速全球扩张，并规模化下一代汗液传感技术。

Epicore Biosystems is a digital health company spun out of Northwestern University's Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory. Epicore has developed advanced sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 1000 companies, the Department of Defense, and the National Institute of Health..

Epicore Biosystems是一家从西北大学Querrey Simpson生物电子学研究所和John Rogers实验室分离出来的数字健康公司。Epicore开发了先进的汗液感应可穿戴设备，提供实时的个性化健康洞察。其临床验证的生物可穿戴解决方案和云分析已在全球部署，并被领先的《财富》1000强公司、国防部和国家卫生研究院授权使用。